• Reports

      Reports

      Stay ahead and make informed decisions with Delvens insightful analysis on key business and technological trends.

      How We Can help you
      • Healthcare
      • Automotive
      • Chemicals & Materials
      • Aerospace & Defense
      • Semiconductors & Electronics
      • Food & Beverages
      • Pharmaceutical
      • IT & Telecom
      • Energy
      • Consumer Goods & Services
  • Best Practice Guide

      Best Practice Guides

      The Delvens Best Practice Team offers practical tactics, procedures, and resources to help you address the major growth-related dos and don'ts.

      How We Can help you
      • Healthcare
      • Automotive
      • Chemicals & Materials
      • Aerospace & Defense
      • Semiconductors & Electronics
      • Food & Beverages
      • Pharmaceutical
      • IT & Telecom
      • Energy
      • Consumer Goods & Services
  • Expertise

      Expertise

      Delvens' decades of experience helps you to strategize, plan, optimize and win.

      See What we can do
      • Syndicated Research
      • Custom Research
      • Consulting
      • Implementation Support
      • Audio-Video Infographic Workshops
      • Subscription Model
      • Bundle Reports Model
      • Best Practice Guides
  • Innovation

      Innovation

      Gain thought-provoking insights on some of the biggest trends in the world to guide you in the phase of innovation.

      Let's Innovate

      Latest Chronicles

      Pharma Businesses

      Pharma businesses that are rewired will win in the digital era

      13th July 2023

      Featured Chronicle

      ESG

      Why ESG is more important than ever!

      4th November 2022
  • Innovation
  • Explore

      Explore

      From accelerating growth and providing strategic vision to the world's biggest brands, to lunch-break sneaker shopping on Melrose, and thirsty Thursdays at the local pubs. We have a Hustling atmosphere because growing together should be fun, or why do it?

      Let's Explore Something

      About

      • Who We Are
      • Why Choose Us
      • Research Methodology
      • Careers
      • Contact

      Help

      • Customer FAQs
      • How To Order
      • Delivery Method
      • Return Policy
      • Privacy Policy
      • Terms of Use
  • Newscast

      Blogs

      The Pros and Cons of Cloud Computing

      The Pros and Cons of Cloud Computing

      13th July 2023
      Let's Read

      Press Room

      Healthcare AI Innovation

      Healthcare AI innovation: a new era of patientcare

      13th July 2023
      Let's Understand

      Article

      Electric Vehicle Thermal Management System (EVTMS) Market

      19th May 2023
      Let's Study
  • Newscast
      • Blog
      • Article
      • Pressroom
Healthcare Icon

Digital Therapeutics (DTx) Market – Trends Forecast Till 2030

Digital Therapeutics (DTx) Market, by Product (Software and Devices), Sales Channel (Business-to-Business and Business-to-Consumers), Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS), Disease Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID) and Others) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).

  • Published Date : August 2023
  • Base Year Estimate : 2022
  • Report ID : D-HC-DTM-1486
  • Format :
  • Number of Pages : 590
  • Domain : Healthcare
  1. Healthcare
  2. Digital Therapeutics (DTx) Market – Trends Forecast Till 2030
Buy Now Get Free Sample Now
REPORT SYNOPSIS
Market Snapshot Market Overview Delvens Industry Expert's Standpoint Market Portfolio Key Findings Regional Analysis Competitive Landscape Recent Developments Reasons to Acquire Report Scope
Table Of Content Frequently Asked Questions

Market Snapshot

Market Overview

The global Digital Therapeutics (DTx) market size was estimated at USD 5.47 billion in 2023 and is projected to reach USD 28.68 billion in 2030 at a CAGR of 26.70% during the forecast period 2023-2030.

Digital therapy provides patients with evidence-based therapeutic interventions. It is provided with software and devices designed to manage or treat medical conditions. Digital therapy software can be used alone or in conjunction with another device, medication or treatment to achieve patient treatment and health outcomes. The design, clinical validation, usability and data security of digital therapies are based on state-of-the-art technology according to best practices. These products have been tested and approved by regulatory authorities before use. In addition, digital therapies provide patients, healthcare providers and payers with smart, easy-to-use tools to treat a variety of diseases through interventions such as high-quality, safe and effective evidence-based cards.

The increase in the use of smartphones and tablets and health applications, the need to control healthcare costs, significant benefits to the entire process of treatment and the increase in the incidence of chronic diseases are driving the growth of the global digital therapy market. The major factors driving the market growth are the increase in the incidence of preventable chronic diseases and the increase in public health funding. Emerging markets also offer companies significant growth opportunities in the coming years. Moreover, strong potential products coming to the market during the forecast period are also beneficial for market participants. Factors such as cost-effectiveness of digital health technologies for providers and patients and increasing need for integrated health systems and patient-centric care are expected to drive market growth during the forecast period.

However, lack of understanding of digital therapies in developing countries and patient privacy concerns are hindering market growth. Developers or manufacturers of digital therapies do not guarantee the security of patient data. Consumers fear that these programs will not be able to protect the confidentiality of their health information. Fear of patient privacy complicates the implementation of digital therapies. In addition, the fear of data compromise or technology being subjected to unwanted personal surveillance is hindering the growth of the digital therapy products market.

The digital therapeutics market has been positively impacted by the COVID-19 pandemic due to awareness of the importance of digital health, prevalence of mental illness and substance abuse worldwide. In addition, people had to stay at home during the pandemic, which led to reduced physical activity, unhealthy lifestyles and mental stress, which in turn increased the prevalence of chronic diseases. Therefore, the demand for DTx equipment and software is increasing worldwide. Recent relaxation of regulatory approvals for DTx-based therapies is further contributing to market growth. For example, the US FDA issued interim guidance on Pear Therapeutics' mental health products during the COVID-19 pandemic.

Delvens Industry Expert's Standpoint

Digital Therapeutics (DTx) uses evidence-based, clinically-evaluated software and devices to deliver medical interventions directly to patients to treat, manage and prevent a wide range of diseases and disorders. These digital modalities help minimize gaps in healthcare delivery by delivering treatment through smartphones, mobile devices, and similar modalities. Digital software solutions support medication adherence through personalized care that drives long-term patient behavior change. Additionally, for patients with chronic conditions such as diabetes and chronic obstructive pulmonary disease, these software solutions play an important role in ensuring patient adherence to recommended doses. Therefore, the digital therapeutics market is projected to be driven by the great potential of digital therapeutics in the coming years.

Market Portfolio

Key Findings

  • The Product segment is further fragmented into Software and Devices. The software segment is the largest and fastest growing segment that dominated the market and is expected to continue this trend during the forecast period due to continuous improvement of firmware and device software’s.
  • The Sales Channel segment is further bifurcated into Business-to-Business and Business-to-Consumers. The business-to-consumers segment is the largest and the fastest growing segment which exhibited the highest growth and is expected to continue this trend during the forecast period. This is happening due to the direct contact between the consumers removing the middlemen and having clear understanding of the needs of the consumers.
  • The Application segment is further bifurcated into Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS), Disease Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID) and Others. The diabetes segment dominated the market with the largest market share. Factors that drive the segment growth include the growing prevalence of diabetes and other chronic diseases. The increasing prevalence of diabetes is boosting the need to develop individualized solutions for treating diabetics.
     
  • The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America is estimated to account for the largest market share during the forecast period owing to Favorable reimbursement scenarios focused on improved tracking and diagnosis, and improved quality of life through increased use of digital health products.

Regional Analysis

North America to Dominate the Market

  • North America is estimated to account for the largest market share during the forecast period owing to favorable reimbursement scenarios focused on improved tracking and diagnosis, and improved quality of life through increased use of digital health products.
     
  • Moreover, strategic initiatives undertaken by key players in this region, such as new product launches and mergers & acquisitions, are expected to result in lucrative growth.

 

Competitive Landscape

  • Omada Health, Inc.
  • Welldoc, Inc
  • Kaia Health
  • 2MORROW, Inc.
  • Proteus Digital Health, Inc.
  • Akili Interactive Labs, Inc.
  • Pear Therapeutics, Inc.
  • Resmed, Inc. (Propeller Health)
  • Fitbit, Inc. (Twine Health, Inc.)
  • Click Therapeutics, Inc.
  • Livongo Health, Inc.
  • Voluntis, Inc.
  • Medtronic Plc.
  • Happify, Inc.
  • Canary health
  • Noom, Inc.
  • HYGIEIA
  • DarioHealth Corp.
  • BigHealth
  • GAIA AG
  • Limbix Health, Inc.